OHSU's Mitalipov proposes path forward for germline gene editing

Germline gene editing pioneer Shoukhrat Mitalipov has weighed in on therapeutic use of the technology, writing in a Nature Medicine perspective that it should only be applied when it can convert a mutated gene to the wild-type version. Such a move would cut off many nearer-term therapeutic applications and push human germline editing further into the future, since technologies for gene

Read the full 618 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE